乾癬薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Psoriasis Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST05013 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、乾癬薬の世界市場について調査・分析し、乾癬薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（腫瘍壊死因子阻害剤、インターロイキン阻害剤、その他）、用途別（トピックス、全身、生物製剤）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の乾癬薬市場動向 ・主要企業別マーケットシェア ・乾癬薬の種類別市場規模2014-2019 （腫瘍壊死因子阻害剤、インターロイキン阻害剤、その他） ・乾癬薬の用途別市場規模2014-2019 （トピックス、全身、生物製剤） ・乾癬薬の北米市場：主要企業・種類別/用途別市場規模 ・乾癬薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・乾癬薬の中国市場：主要企業・種類別/用途別市場規模 ・乾癬薬の日本国内市場：主要企業・種類別/用途別市場規模 ・乾癬薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・乾癬薬のインド市場：主要企業・種類別/用途別市場規模 ・乾癬薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AbbVie、Amgen、Johnson & Johnson、Novartis、Eli Lilly & Company、AstraZeneca、Celgene Corporation、UCB、Merck） ・乾癬薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Psoriasis is a genetic condition that may not be present at birth. The condition may be triggered by certain environmental and genetic factors. Changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diet, and sedentary living, which makes people more prone to this condition.In 2018, the global Psoriasis Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 9.2% during 2019-2025.

This report focuses on the global Psoriasis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriasis Drugs development in United States, Europe and China.

The key players covered in this study
AbbVie
Amgen
Johnson & Johnson
Novartis
Eli Lilly & Company
AstraZeneca
Celgene Corporation
UCB
Merck

Market segment by Type, the product can be split into
Tumor Necrosis Factor Inhibitor
Interleukin Inhibitors
Others

Market segment by Application, split into
Topicals
Systemic
Biologics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Psoriasis Drugs status, future forecast, growth opportunity, key market and key players.
To present the Psoriasis Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Psoriasis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Psoriasis Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Tumor Necrosis Factor Inhibitor
1.4.3 Interleukin Inhibitors
1.4.4 Others
1.5 Market by Application
1.5.1 Global Psoriasis Drugs Market Share by Application (2014-2025)
1.5.2 Topicals
1.5.3 Systemic
1.5.4 Biologics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Psoriasis Drugs Market Size
2.2 Psoriasis Drugs Growth Trends by Regions
2.2.1 Psoriasis Drugs Market Size by Regions (2014-2025)
2.2.2 Psoriasis Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Psoriasis Drugs Market Size by Manufacturers
3.1.1 Global Psoriasis Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Psoriasis Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Psoriasis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Psoriasis Drugs Key Players Head office and Area Served
3.3 Key Players Psoriasis Drugs Product/Solution/Service
3.4 Date of Enter into Psoriasis Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Psoriasis Drugs Market Size by Type (2014-2019)
4.2 Global Psoriasis Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Psoriasis Drugs Market Size (2014-2019)
5.2 Psoriasis Drugs Key Players in United States
5.3 United States Psoriasis Drugs Market Size by Type
5.4 United States Psoriasis Drugs Market Size by Application

6 Europe
6.1 Europe Psoriasis Drugs Market Size (2014-2019)
6.2 Psoriasis Drugs Key Players in Europe
6.3 Europe Psoriasis Drugs Market Size by Type
6.4 Europe Psoriasis Drugs Market Size by Application

7 China
7.1 China Psoriasis Drugs Market Size (2014-2019)
7.2 Psoriasis Drugs Key Players in China
7.3 China Psoriasis Drugs Market Size by Type
7.4 China Psoriasis Drugs Market Size by Application

8 Japan
8.1 Japan Psoriasis Drugs Market Size (2014-2019)
8.2 Psoriasis Drugs Key Players in Japan
8.3 Japan Psoriasis Drugs Market Size by Type
8.4 Japan Psoriasis Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Psoriasis Drugs Market Size (2014-2019)
9.2 Psoriasis Drugs Key Players in Southeast Asia
9.3 Southeast Asia Psoriasis Drugs Market Size by Type
9.4 Southeast Asia Psoriasis Drugs Market Size by Application

10 India
10.1 India Psoriasis Drugs Market Size (2014-2019)
10.2 Psoriasis Drugs Key Players in India
10.3 India Psoriasis Drugs Market Size by Type
10.4 India Psoriasis Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Psoriasis Drugs Market Size (2014-2019)
11.2 Psoriasis Drugs Key Players in Central & South America
11.3 Central & South America Psoriasis Drugs Market Size by Type
11.4 Central & South America Psoriasis Drugs Market Size by Application

12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Psoriasis Drugs Introduction
12.1.4 AbbVie Revenue in Psoriasis Drugs Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Psoriasis Drugs Introduction
12.2.4 Amgen Revenue in Psoriasis Drugs Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Psoriasis Drugs Introduction
12.3.4 Johnson & Johnson Revenue in Psoriasis Drugs Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Psoriasis Drugs Introduction
12.4.4 Novartis Revenue in Psoriasis Drugs Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Eli Lilly & Company
12.5.1 Eli Lilly & Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Psoriasis Drugs Introduction
12.5.4 Eli Lilly & Company Revenue in Psoriasis Drugs Business (2014-2019)
12.5.5 Eli Lilly & Company Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Psoriasis Drugs Introduction
12.6.4 AstraZeneca Revenue in Psoriasis Drugs Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 Celgene Corporation
12.7.1 Celgene Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Psoriasis Drugs Introduction
12.7.4 Celgene Corporation Revenue in Psoriasis Drugs Business (2014-2019)
12.7.5 Celgene Corporation Recent Development
12.8 UCB
12.8.1 UCB Company Details
12.8.2 Company Description and Business Overview
12.8.3 Psoriasis Drugs Introduction
12.8.4 UCB Revenue in Psoriasis Drugs Business (2014-2019)
12.8.5 UCB Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Psoriasis Drugs Introduction
12.9.4 Merck Revenue in Psoriasis Drugs Business (2014-2019)
12.9.5 Merck Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Psoriasis Drugs Key Market Segments
Table Key Players Psoriasis Drugs Covered
Table Global Psoriasis Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Psoriasis Drugs Market Size Market Share by Type 2014-2025
Figure Tumor Necrosis Factor Inhibitor Figures
Table Key Players of Tumor Necrosis Factor Inhibitor
Figure Interleukin Inhibitors Figures
Table Key Players of Interleukin Inhibitors
Figure Others Figures
Table Key Players of Others
Table Global Psoriasis Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Topicals Case Studies
Figure Systemic Case Studies
Figure Biologics Case Studies
Figure Psoriasis Drugs Report Years Considered
Table Global Psoriasis Drugs Market Size 2014-2025 (Million US$)
Figure Global Psoriasis Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Psoriasis Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Psoriasis Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Psoriasis Drugs Market Share by Regions 2014-2019
Figure Global Psoriasis Drugs Market Share by Regions 2014-2019
Figure Global Psoriasis Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Psoriasis Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Psoriasis Drugs Market Share by Manufacturers (2014-2019)
Figure Global Psoriasis Drugs Market Share by Manufacturers in 2018
Table Global Psoriasis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Psoriasis Drugs Product/Solution/Service
Table Date of Enter into Psoriasis Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Psoriasis Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Psoriasis Drugs Market Size Share by Type (2014-2019)
Figure Global Psoriasis Drugs Market Size Market Share by Type (2014-2019)
Table Global Psoriasis Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Psoriasis Drugs Market Size Share by Application (2014-2019)
Figure Global Psoriasis Drugs Market Size Market Share by Application (2014-2019)
Figure Global Psoriasis Drugs Revenue Market Share by Application in 2018
Figure United States Psoriasis Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Psoriasis Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Psoriasis Drugs Market Share (2018-2019)
Table United States Psoriasis Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Psoriasis Drugs Market Share by Type (2014-2019)
Table United States Psoriasis Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Psoriasis Drugs Market Share by Application (2014-2019)
Figure Europe Psoriasis Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Psoriasis Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Psoriasis Drugs Market Share (2018-2019)
Table Europe Psoriasis Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Psoriasis Drugs Market Share by Type (2014-2019)
Table Europe Psoriasis Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Psoriasis Drugs Market Share by Application (2014-2019)
Figure China Psoriasis Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Psoriasis Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Psoriasis Drugs Market Share (2018-2019)
Table China Psoriasis Drugs Market Size by Type (2014-20189) (Million US$)
Table China Psoriasis Drugs Market Share by Type (2014-2019)
Table China Psoriasis Drugs Market Size by Application (2014-2019) (Million US$)
Table China Psoriasis Drugs Market Share by Application (2014-2019)
Figure Japan Psoriasis Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Psoriasis Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Psoriasis Drugs Market Share (2018-2019)
Table Japan Psoriasis Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Psoriasis Drugs Market Share by Type (2014-2019)
Table Japan Psoriasis Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Psoriasis Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Psoriasis Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Psoriasis Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Psoriasis Drugs Market Share (2018-2019)
Table Southeast Asia Psoriasis Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Psoriasis Drugs Market Share by Type (2014-2019)
Table Southeast Asia Psoriasis Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Psoriasis Drugs Market Share by Application (2014-2019)
Figure India Psoriasis Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Psoriasis Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Psoriasis Drugs Market Share (2018-2019)
Table India Psoriasis Drugs Market Size by Type (2014-2019) (Million US$)
Table India Psoriasis Drugs Market Share by Type (2014-2019)
Table India Psoriasis Drugs Market Size by Application (2014-2019) (Million US$)
Table India Psoriasis Drugs Market Share by Application (2014-2019)
Figure Central & South America Psoriasis Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Psoriasis Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Psoriasis Drugs Market Share (2018-2019)
Table Central & South America Psoriasis Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Psoriasis Drugs Market Share by Type (2014-2019)
Table Central & South America Psoriasis Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Psoriasis Drugs Market Share by Application (2014-2019)
Table AbbVie Company Details
Table AbbVie Revenue in Psoriasis Drugs Business (2014-2019) (Million US$)
Figure AbbVie Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Revenue in Psoriasis Drugs Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table Amgen Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Psoriasis Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis Company Details
Table Novartis Revenue in Psoriasis Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table Novartis Recent Development
Table Eli Lilly & Company Company Details
Table Eli Lilly & Company Revenue in Psoriasis Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly & Company Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table Eli Lilly & Company Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Psoriasis Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Psoriasis Drugs Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table Celgene Corporation Recent Development
Table UCB Company Details
Table UCB Revenue in Psoriasis Drugs Business (2014-2019)(Million US$)
Figure UCB Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table UCB Recent Development
Table Merck Company Details
Table Merck Revenue in Psoriasis Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Psoriasis Drugs Business (2014-2019)
Table Merck Recent Development
Table Global Psoriasis Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Psoriasis Drugs Market Size Share by Regions (2019-2025)
Figure Global Psoriasis Drugs Market Size Share by Regions in 2025
Figure United States Psoriasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Psoriasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Psoriasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Psoriasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Psoriasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Psoriasis Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Psoriasis Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Psoriasis Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Psoriasis Drugs Market Size by Product (2019-2025)
Figure Global Psoriasis Drugs Market Size by Product in 2025
Table Global Psoriasis Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Psoriasis Drugs Market Size by Application (2019-2025)
Figure Global Psoriasis Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---